Immunovant, Inc.
USD38.52
+0.01 (+0.03%)
CEO
Eric Venker
IPO Date
2019-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.61
Prev. Close
$38.51
Day Low
$38.24
Day High
$39.13
52W Low
$14.32
52W High
$39.28
Market Cap
$7.91B
Volume
0.61M
| -6.3 |
| 31 Mar 2024 | FY | 0.0% | 0.0% | -42.0% | -38.9% | 0.00 | 13.70 | -16.8 |
| 31 Mar 2023 | FY | 0.0% | 0.0% | -58.2% | -52.0% | 0.00 | 9.34 | -9.0 |
| 31 Mar 2022 | FY | 0.0% | 0.0% | -33.4% | -30.4% | 0.01 | 11.52 | -3.9 |
| 31 Mar 2021 | FY | 0.0% | 0.0% | -27.4% | -26.0% | 0.01 | 21.79 | -13.1 |
| 31 Mar 2020 | FY | 0.0% | 0.0% | -70.6% | -60.7% | 0.03 | 7.12 | -10.1 |
| 31 Mar 2019 | FY | 0.0% | 0.0% | -1.8% | -0.1% | 12.22 | 0.85 | -319266.2 |
| 31 Mar 2018 | FY | 0.0% | 0.0% | 9136.0% | -120827.1% | 0.00 | 0.07 | -0.7 |
| -10.4 |
| 30 Sept 2025 | Q2 | 0.0% | 0.0% | -24.3% | -21.7% | 0.00 | 9.07 | -5.5 |
| 30 Jun 2025 | Q1 | 0.0% | 0.0% | -19.8% | -18.2% | 0.00 | 12.32 | -5.7 |
| 31 Mar 2025 | Q4 | 0.0% | 0.0% | -15.0% | -13.7% | 0.00 | 11.16 | -6.1 |
| 31 Dec 2024 | Q3 | 0.0% | 0.0% | -31.5% | -26.4% | 0.00 | 6.04 | -8.2 |
| 30 Sept 2024 | Q2 | 0.0% | 0.0% | -24.3% | -21.2% | 0.00 | 7.61 | -9.6 |
| 30 Jun 2024 | Q1 | 0.0% | 0.0% | -16.0% | -14.8% | 0.00 | 13.08 | -11.5 |
| 31 Mar 2024 | Q4 | 0.0% | 0.0% | -12.2% | -11.3% | 0.00 | 13.70 | -15.3 |
| 31 Dec 2023 | Q3 | 0.0% | 0.0% | -7.6% | -7.2% | 0.00 | 22.14 | -29.6 |